Intragastric Balloons Market Competitive Landscape 2024-2033 – Major Players and Strategies

Intragastric balloons refer to a minimally invasive bariatric treatment for obesity that involves placing a medical implant in the stomach to restrict its capacity temporarily. This procedure is designed for individuals with obesity, offering a non-surgical option that does not require general anesthesia. The balloons work by taking up space in the stomach, making individuals feel full and limiting their food intake. They are typically inserted using an endoscope, a long, flexible tube with a camera attached, passed through the mouth into the stomach.

Sizing and Forecast

The intragastric balloons market size has grown rapidly in recent years. It will grow from $17.85 billion in 2023 to $19.89 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to growing obesity rates, rising healthcare expenditure, clinical evidence and FDA approvals, awareness campaigns, improved balloon designs, growing medical tourism.

The intragastric balloons market size is expected to see rapid growth in the next few years. It will grow to $30.75 billion in 2028 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to celebrity endorsements, obesity-related health issues, expansion in emerging markets, an increase in endoscopic procedures, an aging population, and personalized treatment approaches. Major trends in the forecast period include technological innovations, awareness through social media, integration with digital health platforms, artificial intelligence, virtual consultations, and enhanced patient education programs.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/intragastric-balloons-global-market-report

Segmentation & Regional Insights

The intragastric balloons market covered in this report is segmented –

1) By Type: Single, Dual, Triple Intragastric Balloons
2) By Filling Material: Saline Filled, Gas Filled
3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies
4) By Application Areas: Obesity, Diabetes, Diet Control, Weight-loss, Pre-operative Weight Reduction, Other Applications
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users

North America was the largest region in the intragastric balloons market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intragastric balloons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15835&type=smp

Major Driver Impacting Market Growth

The increasing obesity rates are expected to propel the growth of the intragastric balloon market going forward. Obesity rates refer to the prevalence or percentage of a population that is considered obese based on body mass index (BMI) measurements, which is generally defined as having a BMI of 30 or higher. The increasing obesity rates are due to dietary habits, sedentary lifestyles, economic factors, advertising and marketing, genetics and biology, psychological and emotional factors, and urbanization and infrastructure. Obese individuals utilize intragastric balloons as a non-surgical option to aid in weight loss by occupying space in the stomach, promoting feelings of fullness, and reducing food intake. For instance, in May 2023, according to a report published by the Office for Health Improvement & Disparities, a UK-based government agency, in 2021–2022, 25.9% of adults aged 18 years and over in England were estimated to be living with obesity. This was an increase from 2020 to 2021 (25.2%). Therefore, the increasing obesity rates are driving the growth of the intragastric balloon market.

Key Industry Players

Major companies operating in the intragastric balloons market are Medtronic plc, Mayo Clinic, Boston Scientific Corporation, Cleveland Clinic, Mediclinic Group, Spire Healthcare Group plc, Micro-Tech (Nanjing) Co., Ltd, American Hospital Dubai LLC, Silimed GmbH, Apollo Endosurgery Inc., Allurion Technologies Inc., MedicalExpo, ReShape Lifesciences Inc., Districlass Medical SA, Healthware Private Limited, Spatz Medical, Helioscopie SA, Bariatric Solutions International GmbH, HexaHealth Care Pvt. Ltd., USGI Medical Inc. , Inamed Health, Medsil , Obalon Therapeutics Inc., Endalis, Lexel SRL

The intragastric balloons market report table of contents includes:

1. Executive Summary
2. Intragastric Balloons Market Characteristics
3. Intragastric Balloons Market Trends And Strategies
4. Intragastric Balloons Market – Macro Economic Scenario
5. Global Intragastric Balloons Market Size and Growth
.
.
.
32. Global Intragastric Balloons Market Competitive Benchmarking
33. Global Intragastric Balloons Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Intragastric Balloons Market
35. Intragastric Balloons Market Future Outlook and Potential Analysis
36. Appendix